Mechain C, Leger A, Feldman S, Kuttenn F, Mauvais-Jarvis P
Service d'Endocrinologie et Médecine de la Reproduction, Hôpital Necker, Paris.
Presse Med. 1993 Nov 27;22(37):1870-5.
Although rare, thyroid hormone resistance syndrome should be suspected on a biological profile combining high thyroid hormone and non-suppressed TSH plasma levels. Resistance to thyroid hormone can be classified into 3 forms: generalized, pituitary and peripheral, all three showing tissue resistance heterogeneity from one person to another, and from one tissue to another in the same subject. In the generalized and pituitary forms, thyroid hormone levels are high with paradoxically normal or increased TSH levels. The TRH test still stimulates TSH secretion, and only the highest doses of T3 successfully suppress TSH secretion. In the generalized form, euthyroidism is usual, whereas in the pituitary form hyperthyroidism requires treatment in order to lower TSH secretion. In the peripheral form, various symptoms of thyroid hormone deficiency may be observed, contrasting with normal T3, T4 and TSH serum levels, and requiring supraphysiological doses of T3 for correction. In most cases, familial occurrence can be evidenced, with an autosomal dominant or sometimes recessive mode of inheritance. Genetic analysis has identified, in the generalized form, more than 10 mutations of the thyroid hormone receptor beta gene, all resulting in an alteration in the T3 binding domain of the receptor. In the autosomal dominant form, tissue resistance may result from a "dominant inhibitory effect" of the normal receptor function by the mutant receptor. All these thyroid hormone resistance syndromes constitute exceptional models for studying the mechanisms of action of thyroid hormones. Simultaneous observations of the mutated receptors with various clinical and biological phenotypes should further our understanding of thyroid hormone receptor function.
尽管甲状腺激素抵抗综合征较为罕见,但当生物学检查结果显示甲状腺激素水平升高且促甲状腺激素(TSH)血浆水平未被抑制时,应怀疑该病。甲状腺激素抵抗可分为三种形式:全身性、垂体性和外周性,这三种形式在个体之间以及同一受试者的不同组织之间均表现出组织抵抗的异质性。在全身性和垂体性形式中,甲状腺激素水平升高,而TSH水平却反常地正常或升高。促甲状腺激素释放激素(TRH)试验仍能刺激TSH分泌,只有最高剂量的T3才能成功抑制TSH分泌。在全身性形式中,通常为甲状腺功能正常,而在垂体性形式中,甲状腺功能亢进需要治疗以降低TSH分泌。在外周性形式中,可能会观察到各种甲状腺激素缺乏的症状,这与正常的血清T3、T4和TSH水平形成对比,且需要超生理剂量的T3来纠正。在大多数情况下,可以证明为家族性发病,遗传方式为常染色体显性遗传,有时也为隐性遗传。基因分析已确定,在全身性形式中,甲状腺激素受体β基因有10多种突变,所有这些突变均导致受体的T3结合域发生改变。在常染色体显性形式中,组织抵抗可能是由于突变受体对正常受体功能的“显性抑制作用”所致。所有这些甲状腺激素抵抗综合征构成了研究甲状腺激素作用机制的特殊模型。对具有各种临床和生物学表型的突变受体进行同步观察,应能增进我们对甲状腺激素受体功能的理解。